TrustCore Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

TrustCore Financial Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$263	Hold	2	–	–	﹤0.01%	990
2022 Q3	$0	Sell	2 -60	-97%	-$7.45K	﹤0.01%	1108
2022 Q2	$7K	Buy	62 +60	+3,000%	+$7.12K	﹤0.01%	797
2022 Q1	$0	Hold	2	–	–	﹤0.01%	1063
2021 Q4	$0	Hold	2	–	–	﹤0.01%	993
2021 Q3	$0	Buy	2 +1	+100%	+$168	﹤0.01%	1084
2021 Q2	$0	Sell	1 -25	-96%	-$3.85K	﹤0.01%	1082
2021 Q1	$4K	Buy	26 +5	+24%	+$794	﹤0.01%	818
2020 Q4	$3K	Buy	21 +20	+2,000%	+$2.86K	﹤0.01%	814
2020 Q3	$0	Buy	+1	New	+$136	﹤0.01%	878
2019 Q4	–	Sell	-301	Closed	-$30K	–	928
2019 Q3	$30K	Hold	301	–	–	0.01%	447
2019 Q2	$33K	Hold	301	–	–	0.01%	430
2019 Q1	$34K	Buy	+301	New	+$33K	0.01%	364
2018 Q4	–	Sell	-301	Closed	-$37K	–	575
2018 Q3	$37K	Buy	301 +1	+0.3%	+$118	0.01%	351
2018 Q2	$33K	Hold	300	–	–	0.01%	358
2018 Q1	$32K	Hold	300	–	–	0.01%	334
2017 Q4	$32K	Buy	+300	New	+$32.1K	0.01%	330

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CANY

Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TrustCore Financial Services's IBB Position: Q4 2022 in Review

TrustCore Financial Services held its iShares Biotechnology ETF (IBB) position steady in Q4 2022 at 2 shares worth $263. The position accounts for ﹤0.01% of the portfolio, ranked #990.

TrustCore Financial Services first reported a position in IBB in Q4 2017 and has held it in 17 quarters since. The position peaked at $37K in Q3 2018. 903 funds tracked by Wall St. Rank hold IBB as of Q4 2022.

TrustCore Financial Services held 2 shares of iShares Biotechnology ETF worth $263 as of Q4 2022.
TrustCore Financial Services left its iShares Biotechnology ETF share count unchanged in Q4 2022.
iShares Biotechnology ETF made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #990 holding.
TrustCore Financial Services first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 17 quarters since.
TrustCore Financial Services's iShares Biotechnology ETF position peaked at $37K in Q3 2018.
903 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.